nodes	percent_of_prediction	percent_of_DWPC	metapath
Permethrin—CYP3A4—Imiquimod—skin cancer	0.236	0.292	CbGbCtD
Permethrin—CYP3A4—Temozolomide—skin cancer	0.236	0.292	CbGbCtD
Permethrin—CYP3A4—Vismodegib—skin cancer	0.164	0.202	CbGbCtD
Permethrin—CYP3A4—Vemurafenib—skin cancer	0.129	0.16	CbGbCtD
Permethrin—CYP3A4—Docetaxel—skin cancer	0.0444	0.0548	CbGbCtD
Permethrin—Tingling sensation—Imiquimod—skin cancer	0.00898	0.0473	CcSEcCtD
Permethrin—Stinging—Imiquimod—skin cancer	0.00891	0.047	CcSEcCtD
Permethrin—Tingling sensation—Fluorouracil—skin cancer	0.00496	0.0261	CcSEcCtD
Permethrin—Stinging—Fluorouracil—skin cancer	0.00492	0.0259	CcSEcCtD
Permethrin—Numbness—Fluorouracil—skin cancer	0.00481	0.0253	CcSEcCtD
Permethrin—Sensory loss—Fluorouracil—skin cancer	0.0046	0.0242	CcSEcCtD
Permethrin—Pain—Vismodegib—skin cancer	0.00418	0.022	CcSEcCtD
Permethrin—Gastrointestinal pain—Vismodegib—skin cancer	0.004	0.0211	CcSEcCtD
Permethrin—Abdominal pain—Vismodegib—skin cancer	0.00386	0.0204	CcSEcCtD
Permethrin—Erythema—Vemurafenib—skin cancer	0.0037	0.0195	CcSEcCtD
Permethrin—Pruritus—Vismodegib—skin cancer	0.00346	0.0182	CcSEcCtD
Permethrin—Diarrhoea—Vismodegib—skin cancer	0.00334	0.0176	CcSEcCtD
Permethrin—Erythema—Imiquimod—skin cancer	0.00315	0.0166	CcSEcCtD
Permethrin—Vomiting—Vismodegib—skin cancer	0.00311	0.0164	CcSEcCtD
Permethrin—Rash—Vismodegib—skin cancer	0.00308	0.0162	CcSEcCtD
Permethrin—Dermatitis—Vismodegib—skin cancer	0.00308	0.0162	CcSEcCtD
Permethrin—Nausea—Vismodegib—skin cancer	0.0029	0.0153	CcSEcCtD
Permethrin—Hypoaesthesia—Bleomycin—skin cancer	0.00256	0.0135	CcSEcCtD
Permethrin—Body temperature increased—Vemurafenib—skin cancer	0.00239	0.0126	CcSEcCtD
Permethrin—Paraesthesia—Imiquimod—skin cancer	0.00231	0.0122	CcSEcCtD
Permethrin—Erythema—Bleomycin—skin cancer	0.00224	0.0118	CcSEcCtD
Permethrin—Pain—Imiquimod—skin cancer	0.0022	0.0116	CcSEcCtD
Permethrin—Hypoaesthesia—Temozolomide—skin cancer	0.00216	0.0114	CcSEcCtD
Permethrin—Pruritus—Vemurafenib—skin cancer	0.00214	0.0113	CcSEcCtD
Permethrin—Gastrointestinal pain—Imiquimod—skin cancer	0.00211	0.0111	CcSEcCtD
Permethrin—Erythema—Dactinomycin—skin cancer	0.00209	0.011	CcSEcCtD
Permethrin—Diarrhoea—Vemurafenib—skin cancer	0.00207	0.0109	CcSEcCtD
Permethrin—Abdominal pain—Imiquimod—skin cancer	0.00204	0.0107	CcSEcCtD
Permethrin—Body temperature increased—Imiquimod—skin cancer	0.00204	0.0107	CcSEcCtD
Permethrin—Dizziness—Vemurafenib—skin cancer	0.002	0.0105	CcSEcCtD
Permethrin—Hypoaesthesia—Fluorouracil—skin cancer	0.00199	0.0105	CcSEcCtD
Permethrin—Vomiting—Vemurafenib—skin cancer	0.00192	0.0101	CcSEcCtD
Permethrin—Rash—Vemurafenib—skin cancer	0.0019	0.01	CcSEcCtD
Permethrin—Dermatitis—Vemurafenib—skin cancer	0.0019	0.01	CcSEcCtD
Permethrin—Headache—Vemurafenib—skin cancer	0.00189	0.00997	CcSEcCtD
Permethrin—Erythema—Temozolomide—skin cancer	0.00189	0.00997	CcSEcCtD
Permethrin—Pruritus—Imiquimod—skin cancer	0.00182	0.0096	CcSEcCtD
Permethrin—Nausea—Vemurafenib—skin cancer	0.00179	0.00945	CcSEcCtD
Permethrin—Diarrhoea—Imiquimod—skin cancer	0.00176	0.00929	CcSEcCtD
Permethrin—Erythema—Fluorouracil—skin cancer	0.00174	0.00918	CcSEcCtD
Permethrin—Dizziness—Imiquimod—skin cancer	0.0017	0.00898	CcSEcCtD
Permethrin—Paraesthesia—Bleomycin—skin cancer	0.00164	0.00866	CcSEcCtD
Permethrin—Vomiting—Imiquimod—skin cancer	0.00164	0.00863	CcSEcCtD
Permethrin—Rash—Imiquimod—skin cancer	0.00162	0.00856	CcSEcCtD
Permethrin—Dermatitis—Imiquimod—skin cancer	0.00162	0.00855	CcSEcCtD
Permethrin—Headache—Imiquimod—skin cancer	0.00161	0.0085	CcSEcCtD
Permethrin—Pain—Bleomycin—skin cancer	0.00156	0.00825	CcSEcCtD
Permethrin—Nausea—Imiquimod—skin cancer	0.00153	0.00806	CcSEcCtD
Permethrin—Pain—Dactinomycin—skin cancer	0.00146	0.00769	CcSEcCtD
Permethrin—Body temperature increased—Bleomycin—skin cancer	0.00145	0.00762	CcSEcCtD
Permethrin—Hypoaesthesia—Docetaxel—skin cancer	0.00144	0.00758	CcSEcCtD
Permethrin—Gastrointestinal pain—Dactinomycin—skin cancer	0.00139	0.00735	CcSEcCtD
Permethrin—Paraesthesia—Temozolomide—skin cancer	0.00139	0.0073	CcSEcCtD
Permethrin—Abdominal pain—Dactinomycin—skin cancer	0.00135	0.00711	CcSEcCtD
Permethrin—Body temperature increased—Dactinomycin—skin cancer	0.00135	0.00711	CcSEcCtD
Permethrin—Pain—Temozolomide—skin cancer	0.00132	0.00696	CcSEcCtD
Permethrin—Pruritus—Bleomycin—skin cancer	0.00129	0.00682	CcSEcCtD
Permethrin—Paraesthesia—Fluorouracil—skin cancer	0.00128	0.00673	CcSEcCtD
Permethrin—Gastrointestinal pain—Temozolomide—skin cancer	0.00126	0.00665	CcSEcCtD
Permethrin—Erythema—Docetaxel—skin cancer	0.00126	0.00663	CcSEcCtD
Permethrin—Abdominal pain—Temozolomide—skin cancer	0.00122	0.00643	CcSEcCtD
Permethrin—Body temperature increased—Temozolomide—skin cancer	0.00122	0.00643	CcSEcCtD
Permethrin—Pain—Fluorouracil—skin cancer	0.00122	0.00641	CcSEcCtD
Permethrin—Diarrhoea—Dactinomycin—skin cancer	0.00117	0.00615	CcSEcCtD
Permethrin—Vomiting—Bleomycin—skin cancer	0.00116	0.00613	CcSEcCtD
Permethrin—Rash—Bleomycin—skin cancer	0.00115	0.00608	CcSEcCtD
Permethrin—Dermatitis—Bleomycin—skin cancer	0.00115	0.00607	CcSEcCtD
Permethrin—Body temperature increased—Fluorouracil—skin cancer	0.00112	0.00592	CcSEcCtD
Permethrin—Fenoprofen—PTGS2—skin cancer	0.00109	1	CrCbGaD
Permethrin—Pruritus—Temozolomide—skin cancer	0.00109	0.00575	CcSEcCtD
Permethrin—Nausea—Bleomycin—skin cancer	0.00109	0.00573	CcSEcCtD
Permethrin—Vomiting—Dactinomycin—skin cancer	0.00108	0.00572	CcSEcCtD
Permethrin—Rash—Dactinomycin—skin cancer	0.00108	0.00567	CcSEcCtD
Permethrin—Diarrhoea—Temozolomide—skin cancer	0.00106	0.00557	CcSEcCtD
Permethrin—Dizziness—Temozolomide—skin cancer	0.00102	0.00538	CcSEcCtD
Permethrin—Nausea—Dactinomycin—skin cancer	0.00101	0.00534	CcSEcCtD
Permethrin—Pruritus—Fluorouracil—skin cancer	0.00101	0.0053	CcSEcCtD
Permethrin—Vomiting—Temozolomide—skin cancer	0.000981	0.00517	CcSEcCtD
Permethrin—Rash—Temozolomide—skin cancer	0.000973	0.00513	CcSEcCtD
Permethrin—Diarrhoea—Fluorouracil—skin cancer	0.000973	0.00513	CcSEcCtD
Permethrin—Dermatitis—Temozolomide—skin cancer	0.000972	0.00512	CcSEcCtD
Permethrin—Headache—Temozolomide—skin cancer	0.000966	0.0051	CcSEcCtD
Permethrin—Dizziness—Fluorouracil—skin cancer	0.00094	0.00496	CcSEcCtD
Permethrin—Paraesthesia—Docetaxel—skin cancer	0.000921	0.00486	CcSEcCtD
Permethrin—Nausea—Temozolomide—skin cancer	0.000916	0.00483	CcSEcCtD
Permethrin—Vomiting—Fluorouracil—skin cancer	0.000904	0.00476	CcSEcCtD
Permethrin—Rash—Fluorouracil—skin cancer	0.000896	0.00473	CcSEcCtD
Permethrin—Dermatitis—Fluorouracil—skin cancer	0.000895	0.00472	CcSEcCtD
Permethrin—Headache—Fluorouracil—skin cancer	0.00089	0.00469	CcSEcCtD
Permethrin—Pain—Docetaxel—skin cancer	0.000877	0.00463	CcSEcCtD
Permethrin—Nausea—Fluorouracil—skin cancer	0.000844	0.00445	CcSEcCtD
Permethrin—Gastrointestinal pain—Docetaxel—skin cancer	0.000839	0.00442	CcSEcCtD
Permethrin—Abdominal pain—Docetaxel—skin cancer	0.000811	0.00428	CcSEcCtD
Permethrin—Body temperature increased—Docetaxel—skin cancer	0.000811	0.00428	CcSEcCtD
Permethrin—Pruritus—Docetaxel—skin cancer	0.000726	0.00383	CcSEcCtD
Permethrin—Diarrhoea—Docetaxel—skin cancer	0.000702	0.0037	CcSEcCtD
Permethrin—Dizziness—Docetaxel—skin cancer	0.000678	0.00358	CcSEcCtD
Permethrin—Vomiting—Docetaxel—skin cancer	0.000652	0.00344	CcSEcCtD
Permethrin—Rash—Docetaxel—skin cancer	0.000647	0.00341	CcSEcCtD
Permethrin—Dermatitis—Docetaxel—skin cancer	0.000646	0.00341	CcSEcCtD
Permethrin—Headache—Docetaxel—skin cancer	0.000643	0.00339	CcSEcCtD
Permethrin—Nausea—Docetaxel—skin cancer	0.000609	0.00321	CcSEcCtD
